Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azeliragon in Hospitalized COVID-19 or Pneumonia Patients
NCT05815485Phase 3Active, not recruiting
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- May 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azeliragon in coronavirus disease 2019 (COVID-19), pneumonia, sponsored by The University of Texas Medical Branch at Galveston. Started May 2023; status: active, not recruiting.
02
Drugs
azeliragon
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on NCT05815485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05815485.